Cargando…

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review

RATIONALE: Non-small cell lung cancer (NSCLC) patients with brain metastases (BMs) have been found as subjects of poor prognosis. Whole-brain radiotherapy (WBRT), surgery, and stereotactic radiosurgery, epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), or some combinations are t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi, Pu, Yu, Dai, Nan, Wang, Dong, Xu, Mingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748360/ https://www.ncbi.nlm.nih.gov/pubmed/33371090 http://dx.doi.org/10.1097/MD.0000000000023592

Ejemplares similares

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020)

Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)

Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study
por: He, Jinlin, et al.
Publicado: (2021)

Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: A case report and literature review
por: He, Guangzhao, et al.
Publicado: (2016)

The impact of baseline brain metastases on clinical benefits and progression patterns after first-line crizotinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer
por: Chen, Yuqi, et al.
Publicado: (2021)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2016)

Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer: Description of 2 case reports
por: Gozzi, Elisa, et al.
Publicado: (2020)

Penile metastases from primary lung cancer: Case report and literature review
por: Guo, Ling-Chuan, et al.
Publicado: (2017)

Successful treatment of 2 patients with brain metastases from non-small cell lung cancer with epidermal growth factor receptor mutation receiving dacomitinib: A case report
por: Zhao, Songchen, et al.
Publicado: (2021)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Brain metastases from esophageal cancer: A case report
por: Qie, Shuai, et al.
Publicado: (2020)

The circ_VCAN with radioresistance contributes to the carcinogenesis of glioma by regulating microRNA-1183
por: Zhu, Chengbin, et al.
Publicado: (2020)

LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases: An Observational Study
por: Hu, Nan, et al.
Publicado: (2015)

Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report
por: Yan, Hongxia, et al.
Publicado: (2020)

Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
por: Chen, Mu-Tong, et al.
Publicado: (2023)

Musashi1 expression is negatively correlated with numb expression in brain metastases
por: Dong, Yalan, et al.
Publicado: (2020)

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Necrosis on pre-radiotherapy (18)F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer
por: Eren, Gülnihan, et al.
Publicado: (2022)

Case report: pathological complete response in an IIIB non-small cell lung cancer patient after preoperative neoadjuvant nivolumab therapy combined with chemotherapy
por: Li, Luzhen, et al.
Publicado: (2022)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis: A successful case report and review
por: Dong, Yong, et al.
Publicado: (2021)

Long-term survival following radiofrequency ablation of lung metastases in an elderly patient with calcaneal osteosarcoma: A case report and review of the literature
por: Futani, Hiroyuki, et al.
Publicado: (2021)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Recurrent spinal primitive neuroectodermal tumor with brain and bone metastases: A case report
por: Chen, Frank, et al.
Publicado: (2017)

Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: A case report
por: Zhang, Tao, et al.
Publicado: (2020)

Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature
por: Guo, Qiang, et al.
Publicado: (2023)

The usefulness of stereotactic radiosurgery for recursive partitioning analysis class II/III lung cancer patients with brain metastases in the modern treatment era
por: Ha, In Bong, et al.
Publicado: (2019)

Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting
por: Leng, Jiao, et al.
Publicado: (2019)

Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis
por: Shieh, Li-Tsun, et al.
Publicado: (2022)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Elevated pretreatment neutrophil-to-lymphocyte ratio indicate low survival rate in apatinib-treated patients with non-small cell lung cancer: A STROBE-compliant article
por: Wan, Ya-Nan, et al.
Publicado: (2022)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival
por: Tang, Liyuan, et al.
Publicado: (2023)

Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
por: Chen, Xiaoli, et al.
Publicado: (2023)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: A case-control study
por: Hu, Xiaoping, et al.
Publicado: (2020)

Lung metastasis from thyroid cancer: A case report of unusual imaging presentation of lung metastases
por: Song, Wenjing, et al.
Publicado: (2023)

Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer
por: Zhang, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qci4s93mpjjh7il3neni9sthdl